KCNH2 and neoplasm: In preclinical mouse models, the labeled mAb was able to identify hERG1-expressing PDAC tumors either in PDAC xenografts or in transgenic mice that develop tumor in the pancreas due to the expression of mutated Kras and Trp53 in pancreatic ductal cells [128].